The Netherlands Authority for Consumers and Markets (ACM) keeps a close watch on the trends and developments in prescription drugs. One such recent development concerns the manufacturing of orphan drugs by pharmacies (independent ones and hospital pharmacies). This ‘magistral preparation’, as it is called, provides opportunities for lower prices …